Oncoinvent outlines Phase III of ~500-600 patients while extending runway into 2H 2027

Oncoinvent Q3 2026 earnings call: Phase II recruitment, cash runway to 2027, and key safety and efficacy readouts ahead.

CryptoAlerta — análise de criptomoedas e mercado em tempo real